As chronic inflammation has been proven to play an essential role in insulin resistance and metabolic syndrome15,16, we measured inflammatory cytokines in peripheral blood and concluded that RYGB substantially reduced systemic inflammation, as supported by the finding that IL6 and TNFα were decreased in the RYGB group. The gene discussed is TNF; the disease is Insulin resistance.